This inventor holds 42 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 15 EPO patents, primarily in Kinase Inhibitors. Top assignees: Bristol-Myers Squibb Compnay, Institute of Organic Chemistry and Biochemistry, Rega Stichting, V.z.w.. Active years: 1994-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Madison, CT (US) (1994 - 2000)
- Durham, CT (US) (2006 - 2020)
Company Filing History:
35 out of 3,745 
7 out of 50 
7 out of 21 
Years Active: 1994-2020
Areas of Expertise:
Title: Joanne J Bronson: A Trailblazer in the Field of Biaryl Kinase Inhibitors
Introduction:
Joanne J Bronson, hailing from Durham, CT in the United States, is a remarkable innovator and inventor in the realm of biaryl kinase inhibitors. With an impressive portfolio of 42 patents, Joanne has made significant contributions to the field of medicine, particularly in the treatment of conditions such as pain, Alzheimer's disease, Parkinson's disease, and schizophrenia. This article sheds light on Joanne's latest patents, career highlights, collaborations, and their overall impact on the field of pharmaceutical research.
Latest Patents:
Joanne's recent patents have centered around the development of biaryl kinase inhibitors. In her most recent patent, she unveils a series of biaryl compounds (formula I) that have demonstrated the ability to inhibit AAK1 (adaptor associated kinase 1). These compounds hold promising potential for the treatment of various neurological conditions, including pain, Alzheimer's disease, Parkinson's disease, and schizophrenia. Additionally, she has also disclosed compounds specifically aimed at inhibiting AAK1, opening avenues for novel therapeutic strategies.
Career Highlights:
Throughout her professional journey, Joanne has worked with esteemed organizations such as Bristol-Myers Squibb Company and the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences. Her tenure with these companies has been marked by groundbreaking research, resulting in a significant number of patent grants. Her expertise in developing innovative biaryl kinase inhibitors has propelled her to prominence within the pharmaceutical industry.
Collaborations:
Joanne's collaborative efforts have played a pivotal role in her success. Among her notable collaborators are John E Macor and Carolyn Diane Dzierba, who have contributed significantly to the development and refinement of her innovative inventions. Through their combined expertise and contributions, Joanne has been able to realize the full potential of her remarkable discoveries in the field of biaryl kinase inhibitors.
Conclusion:
Joanne J Bronson's relentless pursuit of scientific excellence and her groundbreaking contributions to the domain of biaryl kinase inhibitors have positioned her as a trailblazer in the field of pharmaceutical research. Her patents and inventions in this field have the potential to reshape the landscape of healthcare, offering novel therapeutic options for a range of debilitating conditions. As the world eagerly awaits further advancements in this area, we can look to Joanne's remarkable career as a testament to the power of innovation and determination in advancing medical science and improving the quality of life for millions of people worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile